400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Neuronal Signaling / CGRP Receptor / (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate
CAS No.: 1289023-67-1
Synonyms: BMS-927711;BHV-3000
BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03235479 | Migraine Acut... more >>e Migraine Phonophobia Photophobia Collapse << | Phase 3 | Completed | - | - |
NCT03461757 | Migraine | Phase 3 | Completed | - | - |
NCT03266588 | Migraine | Phase 2 Phase 3 | Active, not recruiting | July 2019 | - |
实验方案
技术信息
CAS号 | 1289023-67-1 | 储存条件 |
|
|
分子式 | C28H28F2N6O3 | 运输 | 蓝冰 | |
分子量 | 534.56 | 别名 | BMS-927711;BHV-3000 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03235479 | Migraine Acut... more >>e Migraine Phonophobia Photophobia Collapse << | Phase 3 | Completed | - | - |
NCT03461757 | Migraine | Phase 3 | Completed | - | - |
NCT03266588 | Migraine | Phase 2 Phase 3 | Active, not recruiting | July 2019 | - |
NCT03237845 | Migraine Disorders ... more >> Photophobia Phonophobia Acute Migraine Collapse << | Phase 3 | Completed | - | - |
NCT03732638 | Migraine | Phase 2 Phase 3 | Recruiting | February 15, 2020 | - |
NCT01430442 | Migraine - Acute | Phase 2 | Completed | - | - |
NCT01445067 | Migraine | Phase 1 | Completed | - | United States, California ... more >> California Clinical Trials Medical Group Glendale, California, United States, 91206 Collaborative Neuroscience Network, Inc. Long Beach, California, United States, 90806 United States, Florida Compass Research, Llc Orlando, Florida, United States, 32806 United States, Ohio Community Research Cincinnati, Ohio, United States, 45255 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网